日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis

一项针对复发/难治性B细胞淋巴瘤的blinatumomab/来那度胺I期研究:毒性、疗效及相关性分析

Tuscano, Joseph M; Othman, Tamer; Frankel, Paul; Ruel, Christopher; Poh, Christina; Herbert, Samantha; Maverakis, Emanual; Merleev, Alexander A; Luxardi, Guillaume; Abedi, Mehrdad; Ranganathan, Raghuveer; Modi, Dipenkumar; Zain, Jasmine; Budde, Elizabeth L; Mei, Matthew; Rosenberg, Aaron S; Hoeg, Rasmus T; Costello, Caitlin; Foss, Francine M; William, Basem M; Holland, H Kent; Sharon, Elad; Streicher, Howard; Danilov, Alexy; Newman, Edward

Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I Trial

顺铂和多柔比星加压腹腔内雾化化疗(PIPAC)治疗伴有腹膜转移的卵巢癌患者的安全性和有效性:一项美国多中心I期试验

Nakamura, Brad; Senguttuvan, Rosemary; Ruel, Nora H; Frankel, Paul H; Yost, Susan E; Cole, Sarah; Chang, Sue; Jung, Alexander; Eng, Melissa; Tinsley, Raechelle; Synold, Timothy; Stewart, Daphne; Wang, Edward; Cohen, Joshua; Villella, Jeannine; Whelan, Richard L; Merchea, Amit; DePeralta, Danielle K; Woo, Yanghee; Raoof, Mustafa; Dellinger, Thanh Hue

Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progress

一项多中心剂量递减I期试验,评估加压腹腔内雾化化疗(PIPAC)紫杉醇联合顺铂与全身紫杉醇治疗复发性卵巢癌患者的疗效:试验进行中

Popat, Vinita; Frankel, Paul H; Ruel, Nora H; Yost, Susan E; Chang, Sue; Wang, Edward; Villella, Jeannine; Whyte, Jill; Whelan, Richard L; Eng, Melissa; Tinsley, Raechelle; Synold, Tim; Han, Ernest; Song, Mihae; Cohen, Joshua; Raoof, Mustafa; Dellinger, Thanh Hue

Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapy

接受腹腔化疗的低级别浆液性卵巢癌患者的致癌信号传导和免疫微环境变化存在差异

Bishara, Isaac; Cosgrove, Patrick A; Majumdar, Sumana; Egelston, Colt A; Flores, Oscar Colunga; Nakamura, Brad; Ruel, Nora; Frankel, Paul H; Yost, Susan E; Chang, Sue; Jung, Alexander; Cristea, Mihaela; Raoof, Mustafa; Bild, Andrea H; Nath, Aritro; Dellinger, Thanh H

Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma

阿特珠单抗联合免疫原性挽救性化疗免疫疗法治疗转化型弥漫性大B细胞淋巴瘤患者

Othman, Tamer; Frankel, Paul; Allen, Pamela; Popplewell, Leslie L; Shouse, Geoffrey; Siddiqi, Tanya; Danilov, Alexey V; Ruel, Nora; Daniels, Shari; Peters, Lacolle; Khoo, Stella; Rosen, Steven T; Sharon, Elad; Villalona-Calero, Miguel; Ruel, Christopher; Tuscano, Joseph; Herrera, Alex F

Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345

更正:Senguttuvan 等人,《紫檀芪在子宫内膜癌中的抗癌作用:一项与醋酸甲地孕酮联合应用的 II 期前瞻性、随机、机会窗口临床试验》,Antioxidants 2025, 14, 345

Senguttuvan, Rosemary N; Cho, Hyejin; Wu, Xiwei; Frankel, Paul H; Ruel, Nora; Yost, Susan E; Kebria, Mehdi; Han, Ernest; Song, Mihae; de Leon, Maria; Invernizzi, Marta; Eng, Melissa; Tinsley, Raechelle; Salehian, Behrouz; Li, Aimin; Schmolze, Daniel; Chang, Sue; Arias-Stella, Javier; Dellinger, Thanh H

The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate

紫檀芪在子宫内膜癌中的抗癌作用:一项与醋酸甲地孕酮联合应用的II期前瞻性、随机、机会窗口临床试验

Senguttuvan, Rosemary N; Cho, Hyejin; Wu, Xiwei; Frankel, Paul H; Ruel, Nora; Yost, Susan E; Kebria, Mehdi; Han, Ernest; Song, Mihae; de Leon, Maria; Invernizzi, Marta; Eng, Melissa; Tinsley, Raechelle; Salehian, Behrouz; Li, Aimin; Schmolze, Daniel; Chang, Sue; Arias-Stella, Javier; Dellinger, Thanh H

Quinoline-Based Neuropilin‑1 Antagonists Exhibit a Pure Antagonist Profile and Block Vascular Endothelial Growth Factor-Induced Pain

基于喹啉的神经纤毛蛋白-1拮抗剂表现出纯拮抗剂特性,并能阻断血管内皮生长因子诱导的疼痛。

Hestehave, Sara; Dragoni, Silvia; Fallon, Philip; Mota, Filipa; Calderon-Rivera, Aida; Gomez, Kimberly; Powell, Jonathan; Patsiarika, Anastasia; Reisinger, Tifelle; Crosby, Stuart; Chan, A W Edith; Steadman, David; Winfield, Natalie; Jarvis, Ashley; Martin, John; Zachary, Ian C; Frankel, Paul; Djordjevic, Snezana; Ruhrberg, Christiana; Khanna, Rajesh; Selwood, David L

The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)

ATR抑制剂Elimusertib联合顺铂治疗晚期实体瘤患者:加州癌症联盟I期试验(NCI 10404)

Parikh, Mamta; Uboha, Nataliya V; Takebe, Naoko; Tam, Kit; Bedard, Philippe L; Wisinski, Kari B; Mittra, Arjun; Yin, Ming; Yang, Yuanquan; Noonan, Anne M; Holleran, Julianne L; Ruel, Christopher; Frankel, Paul; Beumer, Jan H; Newman, Edward M; Danilov, Alexey V; Gore, Steven D; Lara, Primo N Jr

Cancer Survival at a Comprehensive Cancer Center Compared with Surveillance, Epidemiology, and End Results (SEER) Estimates

综合癌症中心癌症生存率与监测、流行病学和最终结果 (SEER) 估计值的比较

Salgia, Ravi; Alvarnas, Joseph; Trisal, Vijay; Vanderplas, Ann; Li, Xiaochen; Arias-Romero, Javier; Fricke, Jeremy; Frankel, Paul; Mambetsariev, Isa; Rice, Hannah; Levine, Harlan; van den Brink, Marcel R M